Markets

Edwards Lifesciences will present at two upcoming investor conferences: the Barclays Global Healthcare Conference on March 11th and the Leerink Partners Global Healthcare Conference on March 13th. Management will discuss strategic priorities, advancements in structural heart disease technologies like TAVR, and critical care monitoring. They will also touch on market dynamics, R&D, and the company’s pipeline. Webcasts will be available on the Edwards Lifesciences investor relations website.

Fortuna Silver Mines has significantly expanded its indicated gold resource at the Diamba Sud Project in Senegal by 73% to 1.25 million ounces. This growth, driven by extensive drilling, highlights West Africa’s potential and Fortuna’s effective exploration strategy. The enhanced resource base improves project economics and valuation, paving the way for potential feasibility studies and further development.

Formation Metals has appointed Roger Rosmus to its new Advisory Board to leverage his extensive financial and investment expertise. This strategic move aims to enhance the company’s navigation of the dynamic metals and mining sector, offering insights into market trends, corporate strategy, and capital allocation. The board’s establishment signals Formation Metals’ proactive approach to growth, critical for addressing evolving demands in critical minerals and sustainable resource management amidst global decarbonization efforts.

Materialise released its 2025 financial results, highlighting resilience and strategic progress in the 3D printing industry. The company showcased revenue growth driven by advancements in medical and industrial applications, alongside significant investments in software and R&D. Materialise is positioned for continued expansion, focusing on AI integration, market reach, and sustainable materials to shape the future of additive manufacturing.

Nine attorneys at Dean Omar Branham Shirley have been recognized for their excellence in plaintiff consumer law. The firm demonstrates deep expertise in complex cases involving deceptive advertising, data privacy, and unfair lending, often requiring a nuanced understanding of technology and business models. Their success highlights the growing need for specialized legal representation in protecting consumers against corporate misconduct and driving broader accountability in an evolving marketplace.

Cosmos Health is expanding its UK retail presence with the launch of its C-Scrub skincare line in Superdrug stores, the UK’s second-largest health and beauty retailer. This strategic move into over 780 Superdrug locations and online aims to reach a vast consumer base and capitalize on the growing demand for science-backed skincare. The expansion highlights Cosmos Health’s integrated model and its ambition for international growth within the competitive beauty market.

The FDA has cleared eyonis® LCS, an AI-powered software for lung cancer screening. This approval allows for its U.S. commercialization, enabling earlier and more accurate detection of lung nodules by analyzing medical images. This advancement, driven by sophisticated AI in healthcare, could significantly improve patient outcomes and survival rates for lung cancer. The company also appointed Oran Muduroglu as President to guide its market growth and development.

EuroDry Ltd. will report its Q4 and full-year 2025 financial results on February 15, 2026, followed by a conference call. The drybulk shipping company, based in Greece, will discuss key performance indicators like TCE rates and vessel utilization. Investors will be looking at industry factors such as global economic growth, geopolitical stability, and supply/demand dynamics in the drybulk market.

Wellgistics Health is making a strategic investment in a stealth AI startup to expand within the $6.3 billion mental health software market. This move signals an aggressive approach to leveraging AI for enhanced mental healthcare delivery, potentially focusing on predictive analytics, personalized treatments, and AI chatbots. The acquisition aims to position Wellgistics Health as a leader in this rapidly growing and increasingly digital sector.